Detection of Extracellular Vesicle RNA Using Molecular Beacons.

Biochemistry Methods Biomolecules Cell Biology Functional Aspects of Cell Biology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
24 Jan 2020
Historique:
received: 06 03 2019
revised: 02 12 2019
accepted: 12 12 2019
pubmed: 21 1 2020
medline: 21 1 2020
entrez: 21 1 2020
Statut: ppublish

Résumé

Extracellular vesicles (EVs) have recently emerged as intercellular conveyors of biological information and disease biomarkers. Identification and characterization of RNA species in single EVs are currently challenging. Molecular beacons (MBs) represent an attractive means for detecting specific RNA molecules. Coupling the MBs to cell-penetrating peptides (CPPs) provides a fast, effective, and membrane-type agnostic means to deliver MBs across the plasma membrane and into the cytosol. Here, we generated RBCs-derived EVs by complement activation and tested the ability of MBs coupled with CPP to detect miRNAs from RBC-EVs. Our results showed that RBC and RBC-EVs miRNA-451a can be detected using MB-CPP, and the respective fluorescence levels can be measured by nano-flow cytometry. MB-based detection of RNA via nano-flow cytometry creates a powerful new analytical framework in which a simple addition of a reagent allows profiling of specific RNA species present within certain EV subsets.

Identifiants

pubmed: 31958756
pii: S2589-0042(19)30527-9
doi: 10.1016/j.isci.2019.100782
pmc: PMC6992906
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100782

Subventions

Organisme : NCI NIH HHS
ID : R01 CA227291
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL126497
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA218500
Pays : United States
Organisme : NCATS NIH HHS
ID : UG3 TR002881
Pays : United States
Organisme : NHLBI NIH HHS
ID : UG3 HL147353
Pays : United States

Informations de copyright

Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6171-6
pubmed: 10339560
Nat Biotechnol. 1996 Mar;14(3):303-8
pubmed: 9630890
Clin Chem. 1998 Mar;44(3):482-6
pubmed: 9510851
Sci Rep. 2017 May 8;7(1):1550
pubmed: 28484218
RNA Biol. 2017 Apr 3;14(4):442-449
pubmed: 28277932
Methods Mol Biol. 2017;1660:15-22
pubmed: 28828644
Methods Mol Biol. 2017;1660:287-294
pubmed: 28828665
Int J Biochem Cell Biol. 2018 Aug;101:74-79
pubmed: 29852248
Sci Rep. 2018 Jan 17;8(1):884
pubmed: 29343745
Cell Host Microbe. 2012 Aug 16;12(2):187-99
pubmed: 22901539
J Extracell Vesicles. 2019 Jun 19;8(1):1597603
pubmed: 31258878
Nat Biotechnol. 1998 Jan;16(1):49-53
pubmed: 9447593
J Proteome Res. 2015 Jun 5;14(6):2367-84
pubmed: 25927954
Nucleic Acids Res. 2004 Apr 14;32(6):e58
pubmed: 15084673
Cell Host Microbe. 2013 May 15;13(5):521-534
pubmed: 23684304
Cell. 2016 Mar 10;164(6):1226-1232
pubmed: 26967288
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17008-13
pubmed: 16284251
Methods Mol Biol. 2010;624:177-93
pubmed: 20217596
Sci Rep. 2016 Nov 14;6:36938
pubmed: 27841303
Nat Protoc. 2006;1(3):1392-8
pubmed: 17406426
Oncol Lett. 2017 Apr;13(4):2021-2026
pubmed: 28454357
Nature. 2015 Jul 9;523(7559):161-2
pubmed: 26106856
Nat Chem. 2014 Aug;6(8):663-4
pubmed: 25054934
Cancer Invest. 2016;34(4):181-8
pubmed: 27031291
Curr Protein Pept Sci. 2003 Apr;4(2):125-32
pubmed: 12678851
Genet Anal. 1999 Feb;14(5-6):151-6
pubmed: 10084107
Nat Commun. 2016 Oct 10;7:12727
pubmed: 27721445
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13308-13
pubmed: 14583593
Am J Physiol Heart Circ Physiol. 2017 Dec 1;313(6):H1162-H1167
pubmed: 28916639
Int J Nanomedicine. 2015 Feb 02;10:975-99
pubmed: 25678787
PLoS One. 2016 Jan 08;11(1):e0144678
pubmed: 26745887

Auteurs

Getulio Pereira de Oliveira (GP)

Division of Allergy and Inflammation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Eric Zigon (E)

Nano Flow Core Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Gaenna Rogers (G)

Nano Flow Core Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Danny Davodian (D)

Division of Allergy and Inflammation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA; Centre for Prehospital and Emergency Research, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.

Shulin Lu (S)

Division of Allergy and Inflammation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Tijana Jovanovic-Talisman (T)

Department of Molecular Medicine, Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.

Jennifer Jones (J)

Laboratory of Pathology Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

John Tigges (J)

Nano Flow Core Facility, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Sanjay Tyagi (S)

Public Health Research Institute, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ, USA.

Ionita Calin Ghiran (IC)

Division of Allergy and Inflammation, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: ighiran@bidmc.harvard.edu.

Classifications MeSH